---
title: "Shandong Xinhua Pharmaceutical Gets China Supplementary Approval for Epinephrine Hydrochloride Injection; Shares Fall 3%"
type: "News"
locale: "zh-CN"
url: "https://longbridge.com/zh-CN/news/267772981.md"
description: "Shandong Xinhua Pharmaceutical Gets China Supplementary Approval for Epinephrine Hydrochloride Injection; Shares Fall 3%"
datetime: "2025-11-28T05:45:35.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/267772981.md)
  - [en](https://longbridge.com/en/news/267772981.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/267772981.md)
---

> 支持的语言: [English](https://longbridge.com/en/news/267772981.md) | [繁體中文](https://longbridge.com/zh-HK/news/267772981.md)


# Shandong Xinhua Pharmaceutical Gets China Supplementary Approval for Epinephrine Hydrochloride Injection; Shares Fall 3%



### 相关股票

- [Xinhua Pharm (000756.CN)](https://longbridge.com/zh-CN/quote/000756.CN.md)
- [SHANDONG XINHUA (00719.HK)](https://longbridge.com/zh-CN/quote/00719.HK.md)

## 相关资讯与研究

- [Glenmark Pharmaceuticals to Launch Potassium Phosphates Injection in March](https://longbridge.com/zh-CN/news/279206533.md)
- [Hengrui Pharmaceuticals Gets Nod to Trial SHR-9803 for Injection](https://longbridge.com/zh-CN/news/278830096.md)
- [SSY Gets China Nod for Production, Registration of Vitamin Injection](https://longbridge.com/zh-CN/news/279036594.md)
- [Cipla says U.S. unit to initiate recall of lanreotide injection](https://longbridge.com/zh-CN/news/278444171.md)
- [Zydus Lifesciences Gets US FDA's Final Approval for Cevimeline Hydrochloride Capsules](https://longbridge.com/zh-CN/news/278987228.md)